Stock CGEN COMPUGEN LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Compugen Ltd.

Equities

CGEN

IL0010852080

Real-time Estimate Cboe BZX
Other stock markets
 12:19:49 2024-05-01 pm EDT 		5-day change 1st Jan Change
1.92 USD -0.52% Intraday chart for Compugen Ltd. -0.79% -4.29%
Mar. 08 Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating MT
Mar. 05 Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024

Evolution of the average Target Price on Compugen Ltd.

Price target over the last 5 years

History of analyst recommendation changes

d68e9adf49ad58c22ff2f59197fb19c4.nxo-8vEzwULYrqKyXnzWQe1zHMwFj6E2J2D5_TjE3jc.x15fwLBDqw-s3-bBGgq4eKQLdqhA5cZXfSaLqVK-qV_LdA3CvUu2cYqa9w~1e16068a2f3dc492b18460cdfdb8336e

Analyst Recommendations on Compugen Ltd.

Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating MT
Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon MT
Oppenheimer Adjusts Compugen's Price Target to $7 From $8, Maintains Outperform Rating MT
Jefferies Downgrades Compugen to Underperform From Hold, Lowers Price Target to $0.50 from $2 MT
EF Hutton Initiates Compugen at Buy With $13 Price Target MT
Oppenheimer Adjusts Compugen PT to $8 From $12, Updates Model to Reflect Evolving Development Strategy; Maintains Outperform Rating MT
Truist Securities Adjusts Compugen's Price Target to $4 From $14, Reiterates Buy Rating MT
JMP Securities Adjusts Price Target on Compugen to $4 From $8, Maintains Market Outperform Rating MT
Oppenheimer Adjusts Compugen Price Target to $12 From $14, Maintains Outperform Rating MT
Stifel Adjusts Compugen's Price Target to $5 From $12, Reiterates Buy Rating MT
Jefferies Downgrades Compugen to Hold From Buy; Price Target is $2 MT
SVB Leerink Adjusts Compugen's Price Target to $9 from $16, Maintains Outperform Rating MT
Oppenheimer Adjusts Compugen's Price Target to $14 From $17, Maintains Outperform Rating MT
Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating MT
COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.93 USD
Average target price
5.333 USD
Spread / Average Target
+176.34%
High Price Target
7 USD
Spread / Highest target
+262.69%
Low Price Target
4 USD
Spread / Lowest Target
+107.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Compugen Ltd.

Truist Securities
Oppenheimer
Jefferies & Co.
EF Hutton
JMP Securities
Stifel Nicolaus
SVB Leerink

Ratings for Compugen Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CGEN Stock
  4. Consensus Compugen Ltd.